or Try an Advanced Search...

    ETF Components for TOKE - Cambria Cannabis ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    TPB A 0.95 5.38
    SNDL F 1.79 5.27
    PM A 1.31 5.13
    MO A 0.80 4.40
    HITI C 1.32 4.38
    SAM C 0.06 4.12
    JAZZ B 3.30 3.40
    UVV B 1.80 2.88
    IIPR F 0.72 2.60
    AFCG D 0.10 1.62
    MAPS B -3.39 0.74

    Represented by ETF Holdings

    Keywords: Cannabis Cigar Cigarette Tobacco Tobacco Products Carcinogens Psychoactive Drugs Smokeless Tobacco Cannabis Smoking Dipping Tobacco Drugs Medicinal Plants Medicine Real Estate Investment Trust S&P 500 Smokeless Tobacco Products Smoking Wholesale Distributor Acute Lymphoblastic Leukemia Alcohol
    Industries: Tobacco Beverages - Brewers Biotechnology Conglomerates Drug Manufacturers - Specialty & Generic Pharmaceutical Retailers REIT - Industrial REIT - Specialty

    Recent News for Cambria Cannabis ETF & its Holdings

    Date Stock Title
    Nov 21 PM PM Stock Rallies 30% in 6 Months: What Should Investors Do Next?
    Nov 21 MO Top Dividend Stock Altria Is Currently Trading In A Buy Zone
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 PM Mohamed El-Erian Warns Against Simplistic Narratives As Trump Plans Aggressive Tariff Strategy: 'The Issue Is Quite Complex'
    Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
    Nov 20 SAM 5 Beverages - Alcohol Stocks Holding Strong Amid Industry Challenges
    Nov 20 IIPR 3 Dividend Stocks On US Exchanges Offering Up To 7.3% Yield
    Nov 20 SAM Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
    Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
    Nov 19 MO Altria Group: Market Share Woes Continue To Undermine This Value Prospect
    Nov 19 SAM Why Boston Beer (SAM) is a Top Momentum Stock for the Long-Term
    Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
    Nov 19 JAZZ Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
    Nov 19 MO Altria Group (MO): High-Yield Dividend Stock Shifting Focus to E-Vapor and Nicotine Pouches
    Nov 18 JAZZ Jazz Pharmaceuticals: High Uncertainty, Low Risk
    Nov 18 JAZZ Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?
    Nov 18 PM 2 High-Yield Dividend Stocks I Can't Stop Buying
    Nov 18 HITI High Tide to Open Third Canna Cabana in Hamilton, Ontario
    Nov 18 AFCG Seeking up to 14% Dividend Yield? Analysts Suggest 2 Dividend Stocks to Buy
    The investment seeks capital appreciation from investments in the global equity markets that have exposure to the broad cannabis industry. Under normal market conditions, at least 80% of the value of the fund’s net assets (plus borrowings for investment purposes) will be invested in Cannabis Companies. The Advisor generally expects to invest in Cannabis Companies across a broad market capitalization spectrum of micro-, small-, and mid-capitalization stocks.
    Cannabis Cannabis In Canada
    Back to the Main TOKE Page...